Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus sufentanil for anesthesia during induced abortion
ChiCTR2300079120Phase 4Not yet recruiting
- Sponsor
- Weihai Municipal Hospital
- Start
- Dec 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine, sufentanil and propofol (2 arms), sponsored by Weihai Municipal Hospital. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
esketaminesufentanilpropofol
Beyond the preview
Go deeper on ChiCTR2300079120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079120.